Virus cocktail takes on hard-to-treat liver tumors
NCT ID NCT07381309
First seen Feb 02, 2026 · Last updated May 25, 2026 · Updated 13 times
Summary
This study tests a new combination approach for people with advanced colorectal cancer that has spread to the liver and cannot be removed by surgery. The treatment includes injecting a cancer-killing virus directly into liver tumors, along with targeted radiation, chemotherapy, immunotherapy, and targeted therapy. The goal is to shrink tumors and possibly make them removable by surgery. About 114 adults aged 18-75 with a specific type of colorectal cancer (MSS/pMMR) will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASIS COLON CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.